{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:37:25Z","timestamp":1770917845667,"version":"3.50.1"},"reference-count":45,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1517\/13543784.2011.562190","type":"journal-article","created":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T16:25:52Z","timestamp":1455294352000},"page":"495-505","source":"Crossref","is-referenced-by-count":5,"title":["Investigational factor Xa inhibitors for thrombosis and acute coronary syndromes"],"prefix":"10.1517","volume":"20","author":[{"given":"Erica","family":"Romualdi","sequence":"first","affiliation":[{"name":"University of Insubria, Research Center on Thromboembolic Disorders and on Antithrombotic Therapies, Department of Clinical Medicine, U.O. Medicina I, Ospedale di Circolo, Viale Borri 56, 21100 Varese, Italy ; ;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Ageno","sequence":"additional","affiliation":[{"name":"University of Insubria, Research Center on Thromboembolic Disorders and on Antithrombotic Therapies, Department of Clinical Medicine, U.O. Medicina I, Ospedale di Circolo, Viale Borri 56, 21100 Varese, Italy ; ;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2011,3,9]]},"reference":[{"key":"e_1_3_1_2_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0673"},{"key":"e_1_3_1_3_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.139402"},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200666110-00001"},{"key":"e_1_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.06.011"},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V108.11.905.905"},{"key":"e_1_3_1_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V106.11.1872.1872"},{"key":"e_1_3_1_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-005-0043-5"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2009.02286.x"},{"key":"e_1_3_1_10_1","unstructured":"European Medicines Agency (EMEA). European public assessment report: Xarelto. Available from: http:\/\/www.emea.europa.eu [Last accessed October 2010]"},{"key":"e_1_3_1_11_1","doi-asserted-by":"publisher","DOI":"10.2165\/0003088-200948010-00001"},{"key":"e_1_3_1_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01602.x"},{"key":"e_1_3_1_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01657.x"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.642074"},{"key":"e_1_3_1_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0800374"},{"key":"e_1_3_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60880-6"},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa076016"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60734-0"},{"key":"e_1_3_1_19_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.3_suppl.338S"},{"key":"e_1_3_1_20_1","first-page":"105","article-title":"Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies","author":"Turpie AG","year":"2010","unstructured":"Turpie AG, Lassen MR, Eriksson BI, Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies. Throm Haemost 2010;105(3) [Epub ahead of print]","journal-title":"Throm Haemost"},{"key":"e_1_3_1_21_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.668020"},{"key":"e_1_3_1_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-05-160143"},{"issue":"26","key":"e_1_3_1_23_1","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Einstein investigators","year":"2010","unstructured":"Einstein investigators. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 2010;363(26):2499-510","journal-title":"N Engl J Med"},{"key":"e_1_3_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2009.11.025"},{"key":"e_1_3_1_25_1","unstructured":"Califf RM. Stroke prevention using the oral direct factor xa inhibitor Rivaroxaban compared with warfarin in patients with non valvular atrial fibrillation (ROCKET AF) [abstract 21839]. American Heart Association's Scientific Sessions; 2010"},{"key":"e_1_3_1_26_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-143-4-200508160-00005"},{"key":"e_1_3_1_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60738-8"},{"key":"e_1_3_1_28_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm070245n"},{"key":"e_1_3_1_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.02939.x"},{"key":"e_1_3_1_30_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.109.029694"},{"key":"e_1_3_1_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02764.x"},{"key":"e_1_3_1_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810773"},{"key":"e_1_3_1_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)62125-5"},{"issue":"1","key":"e_1_3_1_34_1","article-title":"Randomised double-blind comparison of apixaban and enoxaparin for thromboprophylaxis after hip replacement: the ADVANCE-3 trial","volume":"37","author":"Lassen MR","year":"2009","unstructured":"Lassen MR, Gallus A, Raskob GE, Randomised double-blind comparison of apixaban and enoxaparin for thromboprophylaxis after hip replacement: the ADVANCE-3 trial. Pathophysiology of Haemostasis and thrombosis 2009;37(Suppl 1):abstract OC356","journal-title":"Pathophysiology of Haemostasis and thrombosis"},{"key":"e_1_3_1_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.03054.x"},{"key":"e_1_3_1_36_1","volume-title":"Meeting ESC","author":"Connolly SJ","year":"2010","unstructured":"Connolly SJ, Eikelboom J, Flaker G, AVERROES: Apixaban versus acetylsalicylic acid (ASA) to prevent strokes. In: Meeting ESC, editor, Stockholm; 2010. p. abstract 3769"},{"key":"e_1_3_1_37_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.832139"},{"key":"e_1_3_1_38_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270009351883"},{"key":"e_1_3_1_39_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-02-0142"},{"key":"e_1_3_1_40_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-01-0066"},{"key":"e_1_3_1_41_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-05-0273"},{"issue":"1","key":"e_1_3_1_42_1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1160\/TH08-07-0460","article-title":"A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT)","volume":"101","author":"Turpie AG","year":"2009","unstructured":"Turpie AG, Bauer K, Davidson BL, A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT). Thromb Haemost 2009;101(1):68-76","journal-title":"Thromb Haemost"},{"key":"e_1_3_1_43_1","unstructured":"Eriksson BI Turpie AG Lassen MR Prevention of venous thromboembolism with an oral factor Xa inhibitor YM150 after total hip arthroplasty. A dose finding study (ONYX-2)"},{"key":"e_1_3_1_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61454-9"},{"key":"e_1_3_1_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02436.x"},{"key":"e_1_3_1_46_1","doi-asserted-by":"publisher","DOI":"10.2147\/ppa.s3682"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/13543784.2011.562190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T16:47:52Z","timestamp":1770914872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543784.2011.562190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,9]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["10.1517\/13543784.2011.562190"],"URL":"https:\/\/doi.org\/10.1517\/13543784.2011.562190","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,9]]}}}